Elevance Health Inc. (ELV) EBITDA Margin: 4.85%
Is Elevance Health Inc.’s EBITDA margin high or low?
Elevance Health Inc.'s EBITDA margin of 4.85% is 22% below its 5-year average of 6.22%, near the low end of its 5-year range (4.85%–7.23%).
As of Wednesday, June 17, 2026. 10.02% below its 12-month average of 5.39%.
ELV EBITDA Margin Chart
ELV Average EBITDA Margin Chart
ELV Current vs Average EBITDA Margin Chart
ELV EBITDA Margin Metrics
EBITDA MARGIN
4.85%
EBITDA MARGIN AVG TTM
5.39%
EBITDA MARGIN AVG 3Y
5.84%
EBITDA MARGIN AVG 5Y
6.22%
EBITDA MARGIN AVG 10Y
6.70%
EBITDA MARGIN AVG 15Y
7.17%
EBITDA MARGIN AVG 20Y
7.56%
CURRENT VS TTM AVG
-10.02%
CURRENT VS 3Y AVG
-16.99%
CURRENT VS 5Y AVG
-22.00%
CURRENT VS 10Y AVG
-27.62%
CURRENT VS 15Y AVG
-32.40%
CURRENT VS 20Y AVG
-35.86%
ELV Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | $85.70B | 4.85% | 5.39% | 5.84% | 6.22% |
| HCA Healthcare, Inc. (HCA)vs › | $86.23B | 20.64% | 20.16% | 20.49% | 20.85% |
| Cigna Corporation (CI)vs › | $76.25B | 4.22% | 4.42% | 5.04% | 5.39% |
| Boston Scientific Corporation (BSX)vs › | $69.74B | 25.42% | 24.47% | 23.70% | 21.87% |
| Medtronic plc (MDT)vs › | $103.29B | 26.97% | 27.23% | 26.91% | 26.72% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.33B | 40.57% | 39.01% | 39.25% | 44.24% |
| Bristol-Myers Squibb Company (BMY)vs › | $114.19B | 30.18% | 18.37% | 30.35% | 29.39% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $115.02B | 40.28% | 22.34% | 35.25% | 38.74% |
| Cencora, Inc. (COR)vs › | $54.76B | 1.16% | 1.15% | 1.23% | 0.63% |
| Cardinal Health, Inc. (CAH)vs › | $53.10B | 1.40% | 1.13% | 0.75% | 0.34% |
Margin Comparison
Gross Margin
23.2%
EBITDA Margin
4.8%
Operating Margin
3.8%
Net Margin
2.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Elevance Health Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Elevance Health Inc. EBITDA Margin FAQ
- What is the EBITDA margin for Elevance Health Inc. (ELV)?
- The EBITDA margin for ELV stock is 4.85%.
- Is Elevance Health Inc.'s EBITDA margin high or low?
- Elevance Health Inc.'s EBITDA margin of 4.85% is 22% below its 5-year average of 6.22%, near the low end of its 5-year range (4.85%–7.23%).
- What is the TTM average EBITDA margin for Elevance Health Inc. (ELV)?
- The TTM average EBITDA margin for ELV stock is 5.39%.
- What is the 3Y average EBITDA margin for Elevance Health Inc. (ELV)?
- The 3Y average EBITDA margin for ELV stock is 5.84%.
- What is the 5Y average EBITDA margin for Elevance Health Inc. (ELV)?
- The 5Y average EBITDA margin for ELV stock is 6.22%.
- What is the 10Y average EBITDA margin for Elevance Health Inc. (ELV)?
- The 10Y average EBITDA margin for ELV stock is 6.70%.
- What is the 15Y average EBITDA margin for Elevance Health Inc. (ELV)?
- The 15Y average EBITDA margin for ELV stock is 7.17%.
- What is the 20Y average EBITDA margin for Elevance Health Inc. (ELV)?
- The 20Y average EBITDA margin for ELV stock is 7.56%.
Elevance Health Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 4.85% |
| 2024-12-31 | 5.93% |
| 2023-12-31 | 6.12% |
| 2022-12-31 | 6.47% |
| 2021-12-31 | 7.23% |
| 2020-12-31 | 6.71% |
| 2019-12-31 | 7.55% |
| 2018-12-31 | 7.55% |
| 2017-12-31 | 6.21% |
| 2016-12-31 | 7.28% |
| 2015-12-31 | 7.81% |
| 2014-12-31 | 7.87% |
| 2013-12-31 | 7.52% |
| 2012-12-31 | 8.31% |
| 2011-12-31 | 8.26% |
| 2010-12-31 | 9.13% |
| 2009-12-31 | 13.63% |
| 2008-12-31 | 6.70% |
| 2007-12-31 | 10.23% |
| 2006-12-31 | 10.37% |
| 2005-12-31 | 9.12% |
| 2004-12-31 | 8.91% |
| 2003-12-31 | 9.52% |
| 2002-12-31 | 1.93% |
| 2001-12-31 | 5.90% |
| 2000-12-31 | 0.00% |
| 1999-12-31 | 0.00% |
| 1998-12-31 | 0.00% |
Related Metrics
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux